Novartis chief executive says large pharma deals usually don't pay off. But the company remains interested in bolt-on ...

What's News: Google and Novartis are working on a smart contact lens that monitors blood-sugar levels. CBO sees growth in Medicare costs continuing to slow. A million fans gather in Berlin to ...

A Google parent-owned startup is poised to begin clinical trials of its first artificial intelligence-designed drug by year-end, marking a significant milestone in pharmaceutical development as ...

Novartis is expanding its prospects in cardiometabolic disease by striking a deal to acquire Anthos Therapeutics, a company in pivotal testing with a blood clot-preventing drug that could offer ...

Novartis managers went through this type of ... Suspend your disbelief. Google chief executive Larry Page takes this approach. For years he fantasized about a search engine that would give people ...

“AI applied to science is a lot richer than just the language models,” Google DeepMind CEO Demis ... on research with Eli Lilly & Co. (LLY) and Novartis (NVS) to leverage its AI technology ...

WASHINGTON, Jan 15 - A federal appeals court temporarily paused drugmaker MSN Pharmaceuticals' launch of a generic version of Novartis' (NOVN.S), opens new tab blockbuster heart-failure drug ...

WASHINGTON, Jan 16 - Novartis (NOVN.S), opens new tab won an order from a U.S. appeals court in Washington on Thursday temporarily blocking drugmaker MSN Pharmaceuticals from launching a generic ...

announcing its first pharma partnerships with Eli Lilly and Novartis, worth almost $3 billion. The company – led by Google DeepMind Founder Demis Hassabis and formed just over two years ago ...

Novartis Q4 earnings beat estimates with sales up 16%, driven by strong demand for Entresto, Kesimpta, and Cosentyx. CEO Narasimhan reportedly downplays Entresto's U.S. patent expiration ...